Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 Velvet Velvet +26.11%
#4 Biconomy Biconomy +24.38%
#5 aPriori aPriori +22.89%
#6 Derive Derive +20.93%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Zerebro Zerebro +10.69%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
Pozycja w akcjach #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
Cena akcji
$2.70
Ostatnia synchronizacja: 2023-05-17
Kapitalizacja rynkowa
$4.13M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Graybug Vision, Inc. (GRAY)

Kategoria

Healthcare
Historia ceny akcji dla Graybug Vision, Inc. (GRAY)
Najwyższa cena zamknięcia: $3.07 dnia 2023-05-01

Najniższa cena zamknięcia: $208.50 dnia 2020-09-01
Historia cen akcji firmy Graybug Vision, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 -59.99%
2022 -72.75%
2021 -92.01%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE